Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer. [PDF]
Zhang JJ +16 more
europepmc +1 more source
Beyond cell cycle control: <i>CDKN2A</i> loss is associated with altered NAD<sup>+</sup> metabolic states and increased sensitivity to NAMPT inhibition in glioblastoma. [PDF]
Dubey S +7 more
europepmc +1 more source
TEAD-targeting small molecules induce a cofactor switch to regulate the Hippo pathway. [PDF]
Guarnaccia AD +16 more
europepmc +1 more source
Deploying the high-throughput virtual screening (HTVS) approach for the identification of new lactate dehydrogenase (LDH) inhibitors with anticancer assets. [PDF]
Huang Y +7 more
europepmc +1 more source
Related searches:
Gene analysis and clinical features of 22 GNE myopathy patients
Neurological Sciences, 2022GNE myopathy is an autosomal recessive distal myopathy caused by a biallelic mutation in UDP-N-acetylglucosamine 2-epomerase/N-acetylmannosamine kinase. In this study, we discuss the clinical features, pathological characteristics, genetic profiles, and atypical clinical manifestations of 22 Chinese GNE patients.Retrospective analysis was performed for
Xuan Guo +6 more
openaire +4 more sources
Comparison of Lectins as Staining Biomarkers for GNE Myopathy Gene Therapy
GNE myopathy (GNEM) is an autosomal recessive disease in which mutations in the GNE gene lead to skeletal muscle weakness and progressive wasting. GNE encodes an essential enzyme of the sialic acid (SA) biosynthetic pathway; thus, decreased SA levels in
Kelly E. Crowe
openalex +2 more sources
Disease mechanisms associated with mutations of the GNE gene
The GNE gene encodes the rate-limiting, bifunctional enzyme of sialic acid biosynthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase. GNE mutations underlie two distinct disorders, dominant inherited sialuria characterized by dramatically increased sialic acid levels and recessive hereditary inclusion body myopathy (HIBM), characterized by decreased ...
Marjan Huizing
openalex +2 more sources
Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy
AbstractBackgroundHereditary inclusion body myopathy (HIBM) is an autosomal recessive adult onset myopathy. It is characterized by mutations of the GNE (UDP‐N‐acetylglucosamine 2‐epimerase/N‐acetylmannosamine kinase) gene. Afflicted patients have no therapeutic options.
Gregory Nemunaitis +13 more
openalex +3 more sources
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene
The term hereditary inclusion-body myopathies (h-IBM) refers to several syndromes with autosomal recessive (AR) or dominant inheritance.1 Although clinical presentation may vary among different forms, they all lead to severe disability and share common findings at muscle biopsy.
Aldobrando Broccolini +8 more
openalex +4 more sources

